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Abstract
Backgrounds: Over 50% of antibiotics prescriptions are for outpatients with acute respiratory infections (ARI). Many of them
are not needed and thus contribute both avoidable adverse events and pressures toward the development of bacterial
resistance. Could a clinical decision support system (CDSS), interposed at the time of electronic prescription, adjust
antibiotics utilization toward consensus treatment guidelines for ARI?
Methods: This is a retrospective comparison of pre- (2002) and post-intervention (2003–2006) periods at two
comprehensive health care systems (intervention and control). The intervention was a CDSS that targeted fluoroquinolone
and azithromycin; other antibiotics remained unrestricted. 7000 outpatients visits flagged by an ARI case-finding algorithm
were reviewed for congruence with the guidelines (antibiotic prescribed-when-warranted or not-prescribed-when-
unwarranted).
Results: 3831 patients satisfied the case definitions for one or more ARI: pneumonia (537), bronchitis (2931), sinusitis (717)
and non-specific ARI (145). All patients with pneumonia received antibiotics. The relative risk (RR) of congruent prescribing
was 2.57 (95% CI = (1.865 to 3.540) in favor of the intervention site for the antibiotics targeted by the CDSS; congruence did
not change for other antibiotics (adjusted RR = 1.18 (95% CI = (0.691 to 2.011)). The proportion of unwarranted prescriptions
of the targeted antibiotics decreased from 22% to 3%, pre vs. post-intervention (p,0.0001).
Conclusions: A CDSS interposed at the time of e-prescription nearly extinguished unwarranted use targeted antibiotics for
ARI for four years. This intervention highlights a path toward sustainable antibiotics stewardship for outpatients with ARI.
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Introduction
Microorganisms resistant to antibiotics increase the mortality,
morbidity and costs of infections. Without a drug development
infrastructure that can keep pace with the rapidly evolving
resistance mechanisms, these organisms are expected to threaten
public health for years to come.
Because exposure to antibiotics is a key promoter of bacterial
resistance [1], efforts aimed at minimizing the unnecessary use of
antibiotics could slow the rate at which resistance emerges. To
date, such efforts have largely targeted uncomplicated acute
respiratory infections (ARI) [2], a rubric that includes outpatient
conditions for which antibiotics are routinely over-prescribed,
namely acute bronchitis, acute sinusitis, acute pharyngitis and
nonspecific upper respiratory tract infection (URI) [3]. Traditional
educational methods aimed at health care providers can reduce
unwarranted antibiotics use, but their effect tend to be modest [2]
and ephemeral [4].
In this work, we re-engineered pharmacy processes to interpose
a clinical decision support systems (CDSS) at the time of order
entry for selected antibiotics [5]. The hypothesis was that
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integrating electronic tools within the natural flow of care could
sustainably counteract a persistent form of unwarranted drug use.
Methods
This is a retrospective, observational study designed to assess the
effect of a CDSS on congruence of antibiotics prescribing with
widely endorsed ARI treatment guidelines [6]. The study period
ranged from January 2002 to December 2006. The CDSS
intervention started in January 2003 at the Veterans Affairs (VA)
Maryland Health Care System and continued through the end of
the study period. The VA Salt Lake City Health Care System
served as a control site. The CDSS targeted azithromycin and
gatifloxacin, which had been the most frequently prescribed
antibiotics in outpatients with uncomplicated ARI at the
intervention site. All other outpatient antibiotics remained
unrestricted.
Ethics Statement
The Institutional Review Boards of the participating VA health
systems, the University of Maryland and the University of Utah,
approved the study. The study was granted a waiver of consent as
risks were limited to information confidentiality and it involved a
large number of participants.
Description of the Intervention
Setting and process engineering. The CDSS intervention
was part of a larger quality improvement initiative that targeted 26
medications and was used by at least 1379 unique providers during
the study period. The CDSS: 1) deployed drug-specific guideline
recommendations as clickable choices during order entry; 2)
mined the electronic medical record (EMR) for patient/context
specific information; and 3) based on what the provider had
clicked on, issued a note documenting the rationale for drug use.
The providers could then accept or modify this note before
committing it to the EMR. The presence of this note was verified
by pharmacy, but its content was not routinely audited.
Antibiotics CDSS. The azithromycin and gatifloxacin CDSS
included treatment paths for the following diseases: community-
acquired pneumonia, acute bronchitis, acute sinusitis, non-specific
upper respiratory infection (URI) and exacerbations of chronic
obstructive pulmonary disease (COPD). An ‘‘Other’’ path
provided access to either drug for provider-supplied indications.
For the community-acquired pneumonia path, providers clicked
on the diagnostic elements that raised their index of suspicion for
pneumonia and were then led to a prescription. For the acute
bronchitis [7], acute sinusitis [8] and non-specific URI [9] paths,
the software first verified that the clinical condition matched the
guideline’s case definition and then sought to identify clinical
circumstances where antibiotics could be warranted. This included
acute bronchitis patients with abnormal vital signs (temperature
.38uC or respiratory rate .22 breath per minute or pulse .100)
or with clinical signs of lung consolidation, and acute sinusitis
patients who were febrile (temperature .38uC) or who had severe
or persistent (7 days or more) symptoms. Under those circum-
stances, the CDSS led to an antibiotic prescription. For cases with
acute bronchitis and sinusitis where guidelines suggested that
antibiotics could be safely withheld, and for all cases with non-
specific URI, the software did not lead to a prescription. Instead,
providers were advised on how to maintain patient satisfaction
when withholding antibiotics. Providers reaching such an outcome
but wishing to prescribe antibiotics anyway could override the
system by using a path known to lead to a prescription (e.g. the
‘‘Other’’ path or the ‘‘Pneumonia’’ path) and then typing their
own rationale for drug use in the CDSS-issued note. They were
also free to prescribe antibiotics not targeted by the CDSS.
Participants
A case-detection algorithm previously found to identify 76% of
patients with an influenza-like illness [10] was applied to EMR-
derived relational databases. Outpatient visits during the study
period (n = 4.1 million) were flagged if providers either assigned an
ARI-related diagnostic code [10] or prescribed a cough suppres-
sant, and if the clinical note documented at least two ARI
symptoms, as assessed by automated text analysis of [10].
Record Review
With the exception of notes generated by the CDSS itself, all
free-text EMR entries on the day of flagged visits were manually
abstracted for data elements needed to assign ARI diagnoses and
treatment. Reviewers cross-validated 10% of each other’s work;
conflicts were resolved through arbitration with a pulmonary
medicine specialist. Inter-rater reliability was determined using
15% of the total sample for the ‘‘cough’’, ‘‘sputum production’’,
‘‘cough duration’’ and ‘‘sputum production duration’’ symptoms
(kappa statistics = 0.80, 0.87, 0.87 and 0.87 respectively at the
intervention site and 0.86, 0.79, 0.91, and 0.92 respectively at the
control site). Structured EMR data elements, such as prescriptions
and vital signs, were extracted from the EMR [10] and later
appended to the review database.
Exclusion, Diagnostic and Treatment Criteria
We reviewed all of the records flagged by the case-detection
algorithm at the intervention site. Based on preliminary results and
published effect sizes [2], we calculated that abstracting 2,000
flagged outpatient encounters would have 80% power to detect a
10% change in congruence at the control site.
Of the 7000 visits manually reviewed, 3169 were excluded
according to pre-defined criteria: 1) not an outpatient (n = 141); 2)
not an ARI (n = 855); 3) not an in-person, initial visit for a given
ARI episode (no prior ARI visit within 3 weeks) (n = 1093); 4) prior
ARI episode(s) during the study period i.e. patients were used only
once (n = 140); 5) stated diagnosis of COPD, whether or not the
visit was related to an exacerbation of this disease (n = 501); 6)
acute pharyngitis as the only ARI diagnosis (n = 431).
A visit was labeled pneumonia if a provider note listed this
diagnosis as likely. Other ARI case definitions and conditions
justifying antibiotics matched that of the guidelines (Table 1)
[7,8,9,11]. Visits for conditions other than pneumonia or non-
specific URI could be labeled with more than one ARI diagnoses.
Antibiotics were categorized as ‘‘warranted’’ if they were justified
for at least one ARI diagnosis. We defined an ARI visit as
‘‘congruent’’ with the guidelines if an antibiotic was either
prescribed or withheld in accordance with the criteria outlined
in Table 1.
Statistical Analysis
Descriptive statistics and results from bivariate tests for
association were generated for the study sample and informed
the multivariable analyses. Multivariable logistic regression and
difference-in-difference regression analyses using a Poisson distri-
bution with a log link and modified Poisson approach to obtain
robust standard error estimates [12] were developed to estimate
the impact of the CDSS intervention on overall antibiotics
prescribing congruence (SAS software v. 9.2, SAS Institute Inc.
Cary, NC). The size of inference tests for covariates in all adjusted
regression models was set a priori at 0.05. Patient-specific covariates
ePrescription-Based Antibiotic Stewardship
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were age, marital status at index visit date, sex and self-reported
race/ethnicity (African-American/other).
Results
Characteristics of Study Patients and ARI Diagnoses
The study included 3831 unique patients with an initial visit for
ARI. Patients were mostly older males (Table 2). The most
common ARI diagnosis was acute bronchitis (76.5% of all ARI
visits), followed by pharyngitis (40.7%), sinusitis (18.7%), pneu-
monia (14.0%) and non-specific URI (3.8%). More than one ARI
diagnosis was found in 56.9% of ARI visits (Table 2).
Effect of the CDSS on Warranted Use of Antibiotics
Of the 624 visits where antibiotics were warranted (Table 3),
most were for pneumonia (n = 537, 86%). All pneumonia patients
received antibiotics. Of the remaining 87 visits, 18 (20.7%) did not
receive antibiotics.
Figure 1 compares pre- vs. post-intervention proportions of ARI
visits prescribed an antibiotic. The upper panel focuses exclusively
on ARI visits where antibiotics were warranted and illustrates that
providers prescribed antibiotics in a high proportion of such visits.
These proportions did not change appreciably from the pre- to the
post-intervention periods at both study sites. The targeted
antibiotics remained the most prescribed of the warranted
antibiotics at both study sites (66.7% vs. 67.2% (Maryland) and
67.6% vs. 68.9% (Utah) of total warranted prescriptions, pre- vs.
post-intervention).
Effect of the CDSS on Unwarranted Use of Antibiotics
The majority of ARI visits did not include documentation
supporting the use of antibiotics (n = 3207 or 83.7% of total ARI
visits, Table 3). For the drugs targeted by the CDSS, the
proportion of unwarranted prescriptions decreased from 22% to
3.3% (p,0.0001) of visits, pre- to post-CDSS (Fig. 1, lower panel).
The equivalent proportion remained unchanged for the Other
antibiotics at the intervention site (30.1% to 30.5%), or for both
the Targeted (16% vs. 20%) and the Other (22% vs. 27%)
antibiotics at the control site.
Effect of CDSS on Overall Antibiotic Prescribing
Congruence with the ARI Guidelines
The proportion of total ARI visits where antibiotics use was
congruent with the guidelines increased from the pre- to the post-
intervention periods at the intervention site (from 0.63 to 0.72,
p = 0.0001), but was unchanged at the control site (from 0.74 to
0.69, p = 0.10). At the intervention site, congruence increased in
the first post-intervention year (0.72 (95% CI = (0.68, 0.75) in
2003) and remained stable afterwards (0.73 (95% CI = (0.69, 0.77)
in 2004, 0.72 (95% CI = (0.69, 0.75) in 2005, and 0.73 (95%
CI = (0.69, 0.78) in 2006). Prevalence ratios of antibiotics
prescribing congruence were obtained by site and by year through
adjusted multivariable logistic regression models. Adjusted multi-
variable difference-in-difference models between the two study
sites, post- vs. pre-intervention periods, revealed a relative risk
(RR) of a congruent prescription to be 1.24 (95% CI = (1.110,
1.391)), in favor of the intervention site. The impact of the
intervention was found to be greatest for the targeted antibiotics
(RR = 2.57; 95% CI = (1.865, 3.540)). Prescribing congruence for
antibiotics not targeted by the intervention was unchanged
(adjusted RR = 1.18; 95% CI = (0.691, 2.011)). No change was
detected in congruence when no antibiotics were prescribed
(adjusted RR = 0.99; 95% CI = (0.990, 1.00)). Favorable adjusted
relative risks persisted for the sub-group of patients without
pneumonia (n = 3294, RR = 1.27, 95% CI = (1.112, 1.457)) and in
patients with acute bronchitis as their only ARI diagnosis
(n = 1233, RR = 1.32; 95% CI = (1.042, 1.678)).
Discussion
In this work, a CDSS interposed treatment guidelines at the
time of electronic order entry for antibiotics frequently used for
outpatients with ARI. We report that the indicated use of the two
antibiotics targeted by the CDSS, azithromycin and gatifloxacin,
remained undiminished, but that their unnecessary use for ARI
was curtailed for a 4-year period. This outcome was not observed
for antibiotics not subject to the CDSS at the intervention and at
the control sites.
The strengths of our study include the long duration of the
intervention, the large sample size, and explicit case definitions
and treatment criteria. Statistical comparisons could be made not
only across the pre vs. post intervention time period, but also
between the targeted and non-targeted antibiotics. Because pre-
and post-intervention data was available from the intervention and
the control site, we could also use a quasi-experimental difference-
in differences approach to control for factors other than the CDSS
that could be contributing to time-dependent changes in
congruence to ARI antibiotics guidelines. In absolute terms, the
overall 9.5% post-intervention decline in unwarranted antibiotic
use for ARI was consistent with the 9.7% median reduction
Table 1. Diagnostic and treatment criteria for ARI.
ARI Condition Diagnostic Criteria Antibiotic Treatment Criteria
Pneumonia Clinician’s documented diagnostic impression Antibiotics always warranted
Acute Bronchitis 1) Acute cough (productive or not) 2) Cough
duration ,21 days
Antibiotics not warranted
Pharyngitis 1) Sore throat 2) Erythematous throat At least three of the following four symptoms/signs: 1) History of fever or
temperature .100.4uF (38uC); 2) Tonsillar exudate; 3) Tender anterior
cervical lymphadenopathy; 4) Absence of cough
Sinusitis 1) Purulent nasal discharge
2) Facial or sinus pain 3) Sinus tenderness
4) Productive cough
Severe symptoms or symptom duration $7 days including purulent nasal
discharge/drainage AND (Maxillary facial or tooth (sinus) pain OR
tenderness)
Non-Specific Acute Upper Respiratory
Infection
1) Absence of a predominant sinus, pharyngeal or
lower airway symptom 2) Nasal discharge 3)
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observed in 30 conventional intervention trials reviewed by Ranji
et al. [2]. What was exceptional is that we could attribute this
decline almost entirely to the only two antibiotics targeted by the
CDSS. For these antibiotics, CDSS filtered utilization apparently
as intended: azithromycin and gatifloxacin remained the most
popular antibiotics when indicated for ARI, but were seldom used
when not needed.
From a safety and tolerability standpoint, providers must be
allowed to override the recommendations of a CDSS. This design
requirement could have allowed providers to bypass the chief aim
of the intervention, which was to convince them not to prescribe
antibiotics unnecessarily for ARI. In a first scenario, they could
have redirected ingrained misutilization to antibiotics not subject
to the CDSS. Had this been the only effect of the intervention, we
estimate that the proportion of ARI visits where antibiotics were
not warranted but where agents other than azithromycin and
gatifloxacin were prescribed should have risen above 50% in the
post-intervention period. Because this proportion remained
unchanged at 30%, our data argue that the CDSS did not merely
shunt misutilization toward alternative, unrestricted drugs. In a
second scenario, providers could have assigned the diagnosis of
‘‘pneumonia’’ more liberally, thereby seemingly justifying antibi-
otics that, in fact, were not indicated. Had providers used this
tactic to justify all unwarranted prescription of the targeted agents,
the proportion of all ARI visits where the targeted antibiotics were
prescribed would have remained unchanged. In reality, this
proportion decreased from 21.7% at baseline to 11.8% post-
intervention. Providing further reassurance that outcomes were
not due to systematic ‘‘gaming’’ of the process, subgroup analyses
that either excluded patients with a pneumonia diagnosis or that
Table 2. Demographics and Diagnoses.
Characteristics Intervention Site N (%)
Control Site
N (%)
Sample Size 2669 1162
Sex
Male 2439 (91.4) 1096 (94.32)
Female 230 (8.6) 66 (5.68)
Self-Reported Race
African American 1775 (66.5) 18 (1.55)
White 601 (22.5) 697 (59.98)
Latino 17 (0.6) 41 (3.53)
Other 10 (0.4) 14 (1.20)
Missing 266 (10.0) 392 (33.73)
Marital Status
Married 792 (29.7) 620 (53.36)
Unmarried 1877 (70.3) 542 (46.64)
Age at Encounter Date, years
Mean 55.6 (13.9) 59.1 (15.55)
Median 53 58
Range 16–97 19–91
ARI Visits, by year
Pre - intervention
2002 373 (14.0) 344 (29.60)
Post - intervention
2003 673 (25.2) 253 (21.77)
2004 481 (18.0) 185 (15.92)
2005 770 (28.9) 225 (19.36)
2006 372 (13.9) 155 (13.34)
ARI Visits, by Condition(s)
Pneumonia 337 (12.6) 200 (17.2)
Bronchitis Only 941 (35.3) 292 (25.1)
Sinusitis Only 57 (2.1) 66 (5.7)
Bronchitis plus pharyngitis 918 (34.4) 281 (24.2)
Bronchitis plus sinusitis 124 (4.6) 109 (9.4)
Bronchitis plus pharyngitis plus sinusitis 139 (5.2) 127 (10.9)
inusitis plus pharyngitis 51 (1.9) 44 (3.8)
on-specific URI 102 (3.8) 43 (3.7)
Counts of ARI Patients and Visits by Characteristics and Sites over the whole study period (2002–2006, n = 3831).
doi:10.1371/journal.pone.0051147.t002
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included only patients whose sole diagnosis was acute bronchitis
yielded findings comparable to those found in the full cohort.
Overall, and even though unintended actions such as those
outlined in the above scenarios could have occurred more than
occasionally, our data suggest that the main effect of the CDSS
was to extinguish unneeded prescriptions of the targeted agents.
Many factors could limit the generalizability of our results. The
study did not employ a randomized allocation process, leaving it
susceptible to well-described biases [13]. The intervention was
implemented at only one site, in the favorable context of a
comprehensive health care system whose providers were familiar
with prescription-based CDSS. As the difference in initial
guideline-congruent prescribing between our two study sites
illustrates, antibiotic prescribing may vary widely between sites
[14,15,16]. Thus, a process similar to the one described in this
study may need adjustments, require significant provider educa-
tion and yet yield different outcomes when implemented
elsewhere. The retrospective data collection meant that symptoms
and signs were assumed to be absent if they were not documented
in the medical record. Thus, ARI episodes could have been missed
or mislabeled, along with the rationale justifying the use of
antibiotics. Although prior studies aimed at improving antibiotics
utilization have returned similar results in VA and non-VA
environments [17], our study population was mostly male and did
not include pediatric age groups or patients with COPD. By
focusing on initial visits for ARI, the study also did not address
ARI patients returning to clinics with unabated or worsening ARI
symptoms. Because multiple practitioners, from medical students
to attending physicians, were often involved in assessing patients,
we could not formally control for potential predictors of
prescribing congruence such as individual practitioners’ prior
practices, level of experience and exposure to the CDSS. These
limitations represent design opportunities for future, hopefully
prospective multisite studies aimed at determining how similar
interventions based would fare when extended to more antibiotics
or to other health care settings.
The rate at which antibiotics are inappropriately used for
ARI remains high but has been decreasing for more than a
decade [18,19,20]. This decline, however, exhibits unfavorable
features in an aging population: it has been concentrated in the
pediatric population and may not be occurring at all in patients
50 years or older [21]. The decline has also not affected all
antibiotics equally, with ARI-related utilization of azithromycin
and fluoroquinolones actually increasing [21]. Thus, there is a
continued need to develop better methods to improve ARI-
related antibiotics use. CDSS have long proven capable to
change prescribing practices, with most published applications
directed at improving drug dosing [22] and safety monitoring
[23,24]. CDSS have also shown the potential to improve
utilization of antibiotics, particularly in the hospital environment
[25,26]. To date, however, examples of demonstrated utility in
the outpatient arena remain scarce [27,28]. In the only study
that included adults with ARI [28], providers were given the
opportunity to consult a stand-alone CDSS in order to receive
patient-specific recommendations. Our intervention is distinctive
in that our CDSS was neither stand-alone nor optional. Instead,
the CDSS was incorporated into a comprehensive EMR and
interposed in the normal workflow leading to an e-prescription.
The CDSS also did more than issue recommendations: it either
did or did not lead to order entry and recorded the prescribing
rationale thereby imparting at least the possibility of future
accountability to a process that was otherwise operating as an
honor system. These features, which had been associated with
CDSS effectiveness in other domains [29,30], were meant for
the intervention to be stronger than what had previously been
attempted for antibiotics stewardship purposes [5]. Yet, the path
illustrated here did not include the vigorous traditional
approaches associated with larger effect sizes in past trials i.e.
one-on-one interactions, concurrent order reviews or practice
audits [2,31]. Our results therefore raise the hope that, at least
for outpatients with ARI, counteracting antibiotic abuse may
not require time-consuming, ultimately unsustainable activities.
From a disease-management standpoint, this CDSS interven-
tion stood at a disadvantage because it targeted only a minority of
the agents that could be used to treat ARIs. The system could
nevertheless have effected large changes in overall guideline-
congruent prescribing for ARI if it had fostered the transmission of
information from providers to providers. Two lines of reasoning
suggest that extra-CDSS educational transmission was not a major
outcome of this intervention: 1) congruence gains were attributable
to improved utilization of the CDSS-targeted antibiotics only; and
2) those gains were realized in the first post-intervention year and
did not further increase afterwards. Thus, prescribing congruence
did not exhibit the gradual expansion that would have been
expected from an increasing the proportion of providers familiar
with the ARI guidelines. Whether or not these outcomes are
particular to a teaching institution with rapid housestaff turnover,
they serve as a reminder that much more work will be required
before we know how to best design, target and integrate
prescription-based interventions to optimize the overall manage-
ment of ARI.
Table 3. Antibiotic Prescriptions by Visits.
Intervention Site Control Site
Antibiotics Warranted Unwarranted Warranted Unwarranted
2002 2003–6 2002 2003–6 2002 2003–6 2002 2003–6
Prescribed (Targeted) 26 225 55 45 48 111 34 100
Prescribed (Others) 13 110 84 583 23 50 51 148
Not Prescribed 0 7 195 1326 6 5 182 404
Total (3831) 39 342 334 1954 77 166 267 652
Number of ARI visits for which antibiotics were given (‘‘Prescribed’’ rows) or withheld (‘‘Not Prescribed’’ row) either in accordance with (‘‘Warranted’’ columns) or against
guideline recommendations (‘‘Unwarranted’’ columns). Columns further separate the visits by 1) study site (Intervention vs. Control Site); 2) time periods (pre-
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Figure 1. Effect of the CDSS on antibiotics use for ARI. Comparison of antibiotic utilization for ARI between the time periods before (dark bars)
or after (light bars) introduction of the CDSS. Y-axis represents proportions of ARI visit where antibiotics were prescribed. For comparisons involving
antibiotics targeted by the CDSS (dark and light bar pairs over the word ‘‘Targeted’’), proportions are given by VTargeted/(VTargeted+VNoAntibiotic), where
VTargeted is the number of visits where targeted antibiotics were prescribed and VNoAntibiotic the number of visits not issued antibiotics. For
comparisons involving other antibiotics (dark and light bar pairs over the word ‘‘Other’’), proportions are given by VOther/(VOther+VNoAntibiotic), where
VOther is the number of visits where Other antibiotics were prescribed. Upper panel only includes ARI visits where antibiotics were indicated; lower
panel only includes those ARI visits where antibiotics were not indicated. Results for the intervention and the control sites are given on the left and
right side of the figure, respectively. Note that proportions of visits where antibiotics were prescribed did not change pre vs. post-intervention, except
for a decrease in Targeted antibiotics use at the intervention site.
doi:10.1371/journal.pone.0051147.g001
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